Navigation Links
Westaim to deregister its common stock in the United States
Date:10/20/2008

CALGARY, Oct. 20 /PRNewswire-FirstCall/ - The Westaim Corporation announced today its intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing under Sections 12(g) and 15(d) of the U.S. Securities and Exchange Act of 1934, as amended.

The deregistration and termination in the United States will have no effect over the Company's common stock or over its shareholders. Westaim's shares will continue to trade on the TSX under the symbol WED. Additionally, the Company does not foresee any material financial effect over its assets, liabilities and results.

During 2007, the bid price of Westaim's common shares listed on Nasdaq was below US$1.00 for longer than 180 days in contravention of Nasdaq Marketplace Rule 4450(a)(5) and as a result the Company's shares were delisted from the Nasdaq and suspended from trading on October 18, 2007.

In connection with the deregistration and termination in the United States, Westaim will immediately file a Form 15F with the SEC. Upon the filing of Form 15F, the Company's reporting obligations under the Exchange Act will be suspended immediately. These reporting obligations will be finally terminated after a 90-day waiting period, provided that the SEC does not raise objections.

The Westaim Corporation's common shares are listed on The Toronto Stock Exchange under the trading symbol WED.

This news release contains forward-looking statements. These statements are based on current expectations that are subject to risks and uncertainties, and Westaim can give no assurance that these expectations are correct. Various factors could cause actual results to differ materially from those projected in such statements, including but not limited to statements regarding the Company's intention to deregister and terminate its reporting obligations associated with its previous Nasdaq listing, the anticipated filing of a Form 15F with the SEC, the date of any filing, the impact of any filing on the Company's reporting obligations, the effect of a filing upon the Company's common stock or its shareholders, continued trading of the Company's stock on the TSX, or the effect of any termination of reporting obligations on the Company's assets, liabilities and results. Westaim disclaims any intention or obligation to revise forward-looking statements whether as a result of new information, future developments or otherwise. Accordingly, readers are advised not to place undue reliance on forward-looking statements, and should not rely on this information at any date other than the date of this news release. All forward-looking statements are expressly qualified in their entirety by this cautionary statement.


'/>"/>
SOURCE Westaim Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Westaim announces sale of iFire Technology Ltd. assets
2. Westaim announces 2008 second quarter results
3. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2008 Second Quarter Results
4. Westaim announces 2008 first quarter results
5. Webcast Advisory - The Westaim Corporation Webcast of Annual Meeting of Shareholders
6. Westaim announces 2007 year-end results
7. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Fourth Quarter Results
8. Westaim reduces ABCP exposure
9. Westaim announces 2007 third quarter results
10. Webcast Advisory - The Westaim Corporation Webcast of Conference Call to Discuss 2007 Third Quarter Results
11. The Westaim Corporation update on status of short-term investments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: